1 f the original product Remicade (infliximab,
Janssen).
2 th Insurance Companies, Schering-Plough, and
Janssen.
3 Elan Corporation,
Janssen Alzheimer Immunotherapy, Wyeth Pharmaceuticals,
4 h Council, Novartis, Sanofi-Aventis, Pfizer,
Janssen,
Astellas, NIHR Clinical Research Network, Swiss
5 ncerteerde Onderzoekacties of KU Leuven; and
Janssen Biologics.
6 t uveitis treated with infliximab (Remicade;
Janssen Biotech, Inc., Titusville, NJ) were identified t
7 tration, Robert Wood Johnson Foundation, and
Janssen Biotech.
8 nts and 57 healthy control subjects) and the
Janssen-
Brain Resource Company study (94 patients and 10
9 Crohn's disease who discontinued infliximab (
Janssen,
Canada, Inc.) and review of the published liter
10 Cancer Research UK,
Janssen-
Cilag, and Chugai Pharma UK.
11 Our initial HTVS results of the
Janssen corporate database identified small focused libr
12 Janssen Diagnostics, the Nuovo-Soldati foundation for ca
13 In this issue of Developmental Cell,
Janssens et al. (2017) demonstrate that the erm enhancer
14 In this issue of Cell,
Janssens et al. demonstrate that, in response to such st
15 US National Institutes of Health,
Janssen Global Public Health.
16 Janssen Research & Development and
Janssen Global Services.
17 ImmunoGold (
Janssen)
labeling using chaperonin antibodies indicated
18 AbbVie, Bristol-Myers Squibb, Gilead,
Janssen,
Merck Sharp & Dohme, ViiV Italy.
19 d Infectious Diseases, Boehringer Ingelheim,
Janssen,
Merck, ViiV Healthcare, Roche, and Monogram Bio
20 metric transition-metal catalysis' by Daniel
Janssen-
Muller et al., Chem.
21 logists under a compassionate-use program by
Janssen Pharmaceutica, as the manufacturer worked toward
22 Galantamine (Reminyl;
Janssen Pharmaceutica, Titusville, NJ) belongs to a clas
23 Asuntos Sociales de Espana, Gilead Sciences,
Janssen Pharmaceuticals, and Merck Laboratories.
24 ork Programme, Inserm-ANRS, Gilead Sciences,
Janssen Pharmaceuticals, Merck Laboratories.
25 are, Merck, Pfizer, F Hoffmann-La Roche, and
Janssen Pharmaceuticals.
26 Janssen Research & Development and Bayer HealthCare AG.
27 Janssen Research & Development and Janssen Global Servic
28 Bayer HealthCare Pharmaceuticals and
Janssen Research & Development, LLC.
29 Bayer HealthCare Pharmaceuticals and
Janssen Research & Development.
30 ViiV Healthcare and
Janssen Research and Development.
31 m one site were excluded by the sponsor, the
Janssen Research Foundation, because of concern about th